Attention Members

Welcome to the Autoimmunity Network, register today to join thousands of Autoimmunity professionals, and get access to invaluable articles, webcasts and data. 

This site is running a new platform. In order to login with your previously existing account, please reset your password here.

CORA 2019 is Coming


Register now and save on fees!




See you in Florence 14-16 March 2019

Mosaic of Autoimmunity: The Novel Factors of Autoimmune Diseases Revisited



Welcome to the Autoimmunity Network
Recent Articles
Specific differences in cancer risk have been observed between systemic lupus erythematosus (SLE) patients and the general population. In past decades, various studies have investigated the relationship between SLE and malignancy
3 days ago
Presence of circulating antinuclear antibodies (ANAs) in patient serum is widely regarded as the hallmark of systemic autoimmune rheumatic disease [1]. A request for a serological ANA screening test is usually a first step for the laboratory diagnosis
5 days ago
The distinction that in areas where helminthic infections are common, autoimmune diseases are less prevalent, led to the investigation of immune modulatory properties of helminths and their derivatives. Such is phosphorylcholine (PC) moieties which are a component of secreted products of helminths.
8 days ago
Systemic lupus erythematosus (SLE) is primarily a relapsing-remitting (RR) disease with unpredictable flares interspersed with periods of clinical quiescence of varying duration. Initial studies on the patterns of disease activity over time described three different subgroups of patients: long quiescent, RR and chronically active after 4.5 years of follow up
10 days ago
Human papillomavirus (HPV) infection is a well-known sexually transmitted disease. A review of 70 countries worldwide showed an age-stratified HPV prevalence ranging from
12 days ago
Originally, neutrophil granulocytes were described to phagocytose and kill bacteria. In 2004, a second mechanism in which neutrophils trap bacteria with extracellular DNA (NETs) was described by Brinkmann et al.
The intention of this paper is to review actual developments in target therapy in SLE. Target therapy includes both the objective of intervention and the aim of treatment. The objective should be linked to the pathophysiologic process of SLE; the aim has to be in any case an improved outcome.
Increased expression of RNA polymerase 1 (POL1) molecular pathway was reported to be associated with increased disease activity in patients with multiple sclerosis (MS). However, the operating molecular mechanisms that characterize the pattern of acute MS relapse activity has not been thoroughly studied.
In the present review, recent findings regarding autoimmune/inflammatory syndrome by adjuvants (ASIA) are described. Patients with ASIA present with complaints such as fatigue, cognitive impairment, arthralgias,myalgias, pyrexia, dry eyes, and dry mouth
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS) in which demyelination and neurodegeneration occurs. The immune system of MS patients is characterized by a dysregulation in the balance between pro- and anti-inflammatory immune cells, whereby both the innate and adaptive immune system are involved
Welcome to the Autoimmunity Network

The Network is a purpose built closed network especially for professionals from multi-disciplinary backgrounds with an interest in learning more about Autoimmune diseases from both a clinical and research perspective.  

CORA 2019 Updates

CORA 2019

Autoimmunity Reviews
Follow @AutoimmunityMD